An open study of efficacy and safety of long-term treatment with mometasone furoate fatty cream in the treatment of adult patients with atopic dermatitis

Citation
J. Faergemann et al., An open study of efficacy and safety of long-term treatment with mometasone furoate fatty cream in the treatment of adult patients with atopic dermatitis, J EUR A D V, 14(5), 2000, pp. 393-396
Citations number
14
Categorie Soggetti
Dermatology
Journal title
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
ISSN journal
09269959 → ACNP
Volume
14
Issue
5
Year of publication
2000
Pages
393 - 396
Database
ISI
SICI code
0926-9959(200009)14:5<393:AOSOEA>2.0.ZU;2-S
Abstract
Background Atopic dermatitis is a severe chronic skin disease often deterio rated by the presence of microorganisms and often responds well to treatmen t with potent corticosteroids. However, the long-term use of potent topical corticosteroids are accompanied by side-effects such as skin atrophy. Objective To study the effect and safety of prophylactic treatment with mom etasone furoate fatty cream (contains hexylene glycol) for 6 months in pati ents with atopic dermatitis. Results Sixty-one of 68 (90%) patients were still free of their disease aft er 6 months of twice weekly treatment and only one showed possible treatmen t related signs of skin atrophy. The number of Staphylococcus aureus and Pi tyrosporum ovale were significantly reduced in cleared patients. Conclusions Mometasone furoate fatty cream is effective and safe both for t reatment and as a prophylaxis in patients with atopic dermatitis.